Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1)

Drug Metabolism and Disposition

Volumn 39, Issue 12, 2011, Pages 2298-2304

  Carew, Michael W ^a   Naranmandura, Hua ^a,b   Shukalek, Caley B ^a   Le, X Chris ^a   Leslie, Elaine M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CACODYLIC ACID; DIMETHYLARSINOUS ACID; ESTRADIOL 17 GLUCURONIDE; GLUTATHIONE DERIVATIVE; METHANEARSONIC ACID; MONOMETHYLARSENIC DIGLUTATHIONE; MONOMETHYLARSONOUS ACID; MULTIDRUG RESISTANCE PROTEIN 1; OPHTHALMIC ACID; ORGANOARSENIC DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL PROTECTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; MEMBRANE TRANSPORT; MEMBRANE VESICLE; PRIORITY JOURNAL;

ARSENICALS; GLUTATHIONE; HELA CELLS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

MAMMALIA;

EID: 81855173552     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.111.041673     Document Type: Article

References (46)

1. Bhalla S, Gordon LI, David K, Prachand S, Singh AT, Yang S, Winter JN, Guo D, O'Halloran T, Platanias LC, et al. (2010) Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms. Br J Haematol 150:365-369.
2. Broeks A, Gerrard B, Allikmets R, Dean M, and Plasterk RH (1996) Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J 15:6132-6143. (Pubitemid 26397885)
3. Carew MW and Leslie EM (2010) Selenium-dependent and -independent transport of arsenic by the human multidrug resistance protein 2 (MRP2/ABCC2): implications for the mutual detoxification of arsenic and selenium. Carcinogenesis 31:1450-1455.
4. Chen GQ, Zhou L, Styblo M, Walton F, Jing Y, Weinberg R, Chen Z, and Waxman S (2003) Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells. Cancer Res 63:1853-1859. (Pubitemid 36460848)
5. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, and Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654. (Pubitemid 23012438)
6. Cole SP and Deeley RG (2006) Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol Sci 27:438-446. (Pubitemid 44051570)
7. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, and Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-5910. (Pubitemid 24375226)
8. Conseil G, Deeley RG, and Cole SP (2005) Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters. Pharmacogenet Genomics 15:523-533. (Pubitemid 41044238)
9. Deeley RG, Westlake C, and Cole SP (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev 86:849-899. (Pubitemid 44033384)
10. Dey S, Ouellette M, Lightbody J, Papadopoulou B, and Rosen BP (1996) An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae. Proc Natl Acad Sci USA 93:2192-2197. (Pubitemid 26079904)
11. Drobná Z, Walton FS, Harmon AW, Thomas DJ, and Stýblo M (2010) Interspecies differences in metabolism of arsenic by cultured primary hepatocytes. Toxicol Appl Pharmacol 245:47-56.
12. Duechler M, Stańczyk M, Czyz M, and Stepnik M (2008) Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells. Cancer Chemother Pharmacol 61:727-737. (Pubitemid 351302028)
13. Emadi A and Gore SD (2010) Arsenic trioxide - An old drug rediscovered. Blood Rev 24:191-199.
14. Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51:257-281.
15. Ghosh M, Shen J, and Rosen BP (1999) Pathways of As(III) detoxification in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 96:5001-5006. (Pubitemid 29214525)
16. Han YH, Kim SZ, Kim SH, and Park WH (2008) Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine. Int J Oncol 33:205-213.
17. Hernández A and Marcos R (2008) Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. Pharmacogenomics 9:1113-1132.
18. Ito K, Olsen SL, Qiu W, Deeley RG, and Cole SP (2001) Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport. J Biol Chem 276:15616-15624.
19. Kala SV, Kala G, Prater CI, Sartorelli AC, and Lieberman MW (2004) Formation and urinary excretion of arsenic triglutathione and methylarsenic diglutathione. Chem Res Toxicol 17:243-249. (Pubitemid 38252504)
20. Kala SV, Neely MW, Kala G, Prater CI, Atwood DW, Rice JS, and Lieberman MW (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275:33404-33408.
21. Kalivas JH (1987) Evaluation of volume and matrix effects for the generalized standard addition method. Talanta 34:899-903.
22. Kobayashi Y, Cui X, and Hirano S (2005) Stability of arsenic metabolites, arsenic triglutathione [As(GS)3] and methylarsenic diglutathione [CH3As(GS)2], in rat bile. Toxicology 211:115-123. (Pubitemid 40603632)
23. Kumagai Y and Sumi D (2007) Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol 47:243-262.
24. Leier I, Jedlitschky G, Buchholz U, Center M, Cole SP, Deeley RG, and Keppler D (1996) ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump. Biochem J 314:433-437. (Pubitemid 26075650)
25. Leslie EM, Bowers RJ, Deeley RG, and Cole SP (2003) Structural requirements for functional interaction of glutathione tripeptide analogs with the human multidrug resistance protein 1 (MRP1). J Pharmacol Exp Ther 304:643-653. (Pubitemid 36152340)
26. Leslie EM, Deeley RG, and Cole SP (2005) Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204:216-237. (Pubitemid 40552845)
27. Leslie EM, Haimeur A, and Waalkes MP (2004) Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Evidence that a tri-glutathione conjugate is required. J Biol Chem 279:32700-32708. (Pubitemid 39014729)
28. Leslie EM, Ito K, Upadhyaya P, Hecht SS, Deeley RG, and Cole SP (2001) Transport of the β-O-glucuronide conjugate of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by the multidrug resistance protein 1 (MRP1). Requirement for glutathione or a non-sulfur-containing analog. J Biol Chem 276:27846-27854.
29. Liu Z, Boles E, and Rosen BP (2004) Arsenic trioxide uptake by hexose permeases in Saccharomyces cerevisiae. J Biol Chem 279:17312-17318. (Pubitemid 38560491)
30. Loe DW, Almquist KC, Cole SP, and Deeley RG (1996a) ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem 271:9683-9689.
31. Loe DW, Almquist KC, Deeley RG, and Cole SP (1996b) Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J Biol Chem 271:9675-9682.
32. Loe DW, Deeley RG, and Cole SP (1998) Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res 58:5130-5136. (Pubitemid 28521173)
33. Long Y, Li Q, and Cui Z (2011) Molecular analysis and heavy metal detoxification of ABCC1/MRP1 in zebrafish. Mol Biol Rep 38:1703-1711.
34. Lorico A, Bertola A, Baum C, Fodstad O, and Rappa G (2002) Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. BBRC 291:617-622. (Pubitemid 34687390)
35. Mann KK, Wallner B, Lossos IS, and Miller WH Jr (2009) Darinaparsin: a novel organic arsenical with promising anticancer activity. Expert Opin Investig Drugs 18:1727-1734.
36. Peklak-Scott C, Townsend AJ, and Morrow CS (2005) Dynamics of glutathione conjugation and conjugate efflux in detoxification of the carcinogen, 4-nitroquinoline 1-oxide: contributions of glutathione, glutathione S-transferase, and MRP1. Biochemistry 44:4426-4433. (Pubitemid 40403984)
37. Qazi SS, Osoria Pérez A, Sam M, and Leslie EM (2011) Glutathione transferase P1 interacts strongly with the inner leaflet of the plasma membrane. Drug Metab Dispos 39:1122-1126.
38. Qian YM, Song WC, Cui H, Cole SP, and Deeley RG (2001) Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. J Biol Chem 276:6404-6411.
39. Rahman I, Kode A, and Biswas SK (2006) Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1:3159-3165.
40. Rahman MM, Ng JC, and Naidu R (2009) Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 31 (Suppl 1):189-200.
41. Renes J, de Vries EG, Nienhuis EF, Jansen PL, and Müller M (1999) ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. Br J Pharmacol 126:681-688. (Pubitemid 29087847)
42. Rosen BP and Liu Z (2009) Transport pathways for arsenic and selenium: a minireview. Environ Int 35:512-515.
43. Song WY, Park J, Mendoza-Cózatl DG, Suter-Grotemeyer M, Shim D, Hörtensteiner S, Geisler M, Weder B, Rea PA, Rentsch D, et al. (2010) Arsenic tolerance in Arabidopsis is mediated by two ABCC-type phytochelatin transporters. Proc Natl Acad Sci USA 107:21187-21192.
44. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Guha N, Freeman C, Galichet L, et al. (2009) A review of human carcinogens-part C: metals, arsenic, dusts, and fibres. Lancet Oncol 10:453-454.
45. Yehiayan L, Pattabiraman M, Kavallieratos K, Wang X, Boise LH, and Cai Y (2009) Speciation, formation, stability and analytical challenges of human arsenic metabolites. J Anal At Spectrom 24:1397-1405.
46. Yoshino Y, Yuan B, Miyashita SI, Iriyama N, Horikoshi A, Shikino O, Toyoda H, and Kaise T (2009) Speciation of arsenic trioxide metabolites in blood cells and plasma of a patient with acute promyelocytic leukemia. Anal Bioanal Chem 393:689-697. (Pubitemid 50331982)